A detailed history of Stifel Financial Corp transactions in Argenx Se stock. As of the latest transaction made, Stifel Financial Corp holds 8,832 shares of ARGX stock, worth $4.98 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,832
Previous 7,662 15.27%
Holding current value
$4.98 Million
Previous $3.29 Million 45.39%
% of portfolio
0.01%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$434.22 - $551.9 $508,037 - $645,723
1,170 Added 15.27%
8,832 $4.79 Million
Q2 2024

Aug 13, 2024

BUY
$356.01 - $451.55 $163,052 - $206,809
458 Added 6.36%
7,662 $3.29 Million
Q1 2024

May 13, 2024

SELL
$356.95 - $413.29 $239,513 - $277,317
-671 Reduced 8.52%
7,204 $2.84 Million
Q4 2023

Feb 12, 2024

BUY
$338.91 - $506.01 $49,141 - $73,371
145 Added 1.88%
7,875 $3 Million
Q3 2023

Nov 13, 2023

BUY
$369.35 - $548.43 $251,158 - $372,932
680 Added 9.65%
7,730 $3.8 Million
Q2 2023

Aug 14, 2023

BUY
$360.14 - $422.58 $288,112 - $338,064
800 Added 12.8%
7,050 $2.75 Million
Q1 2023

May 12, 2023

BUY
$334.23 - $403.65 $56,150 - $67,813
168 Added 2.76%
6,250 $2.33 Million
Q4 2022

Feb 13, 2023

SELL
$342.17 - $402.31 $48,588 - $57,128
-142 Reduced 2.28%
6,082 $2.3 Million
Q3 2022

Nov 14, 2022

BUY
$343.2 - $395.75 $657,571 - $758,257
1,916 Added 44.48%
6,224 $2.2 Million
Q2 2022

Aug 15, 2022

BUY
$269.58 - $378.88 $15,366 - $21,596
57 Added 1.34%
4,308 $1.63 Million
Q1 2022

May 13, 2022

BUY
$254.45 - $351.06 $551,138 - $760,395
2,166 Added 103.88%
4,251 $1.34 Million
Q4 2021

Feb 14, 2022

SELL
$272.01 - $353.03 $5,984 - $7,766
-22 Reduced 1.04%
2,085 $730,000
Q3 2021

Nov 15, 2021

SELL
$295.0 - $350.58 $7,670 - $9,115
-26 Reduced 1.22%
2,107 $636,000
Q2 2021

Aug 13, 2021

SELL
$257.11 - $319.92 $2.65 Million - $3.3 Million
-10,319 Reduced 82.87%
2,133 $642,000
Q1 2021

May 14, 2021

BUY
$268.3 - $380.31 $38,635 - $54,764
144 Added 1.17%
12,452 $3.43 Million
Q4 2020

Feb 12, 2021

BUY
$248.13 - $308.36 $80,145 - $99,600
323 Added 2.7%
12,308 $3.62 Million
Q3 2020

Nov 16, 2020

SELL
$215.51 - $272.51 $50,860 - $64,312
-236 Reduced 1.93%
11,985 $3.15 Million
Q2 2020

Aug 14, 2020

SELL
$127.44 - $232.72 $57,985 - $105,887
-455 Reduced 3.59%
12,221 $2.75 Million
Q1 2020

May 14, 2020

SELL
$108.83 - $165.23 $165,530 - $251,314
-1,521 Reduced 10.71%
12,676 $1.67 Million
Q4 2019

Feb 13, 2020

BUY
$106.59 - $164.21 $199,323 - $307,072
1,870 Added 15.17%
14,197 $2.28 Million
Q3 2019

Nov 19, 2019

SELL
$113.31 - $150.51 $10,537 - $13,997
-93 Reduced 0.75%
12,327 $1.42 Million
Q3 2019

Nov 13, 2019

SELL
$113.31 - $150.51 $16,543 - $21,974
-146 Reduced 1.16%
12,420 $1.43 Million
Q2 2019

Aug 14, 2019

SELL
$115.0 - $141.58 $22,655 - $27,891
-197 Reduced 1.54%
12,566 $1.8 Million
Q1 2019

May 14, 2019

BUY
$98.85 - $134.59 $77,201 - $105,114
781 Added 6.52%
12,763 $1.58 Million
Q4 2018

Feb 13, 2019

SELL
$63.81 - $109.82 $55,004 - $94,664
-862 Reduced 6.71%
11,982 $1.14 Million
Q3 2018

Nov 13, 2018

BUY
$75.5 - $96.63 $969,722 - $1.24 Million
12,844 New
12,844 $990,000
Q1 2018

May 11, 2018

SELL
$56.95 - $85.19 $393,353 - $588,407
-6,907 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$22.57 - $63.56 $155,890 - $439,008
6,907
6,907 $435,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.